Posted by Michael Wonder on 12 May 2020
Decision to fund pancreatic enzymes modified-release granules (Creon Micro)
12 May 2020 - PHARMAC is pleased to announce a decision to fund pancreatic enzymes modified-release granules (Creon Micro) from 1 June 2020 for the treatment of pancreatic enzyme insufficiency, through an agreement with Mylan.
This decision was subject to a consultation letter dated 2 April 2020.
No changes were made to the proposal following consultation feedback.
